DUBLIN--(BUSINESS WIRE)--Sep 11, 2018--The "Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Chronic Obstructive Pulmonary Disease (COPD) - Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Chronic Obstructive Pulmonary Disease (COPD) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Chronic Obstructive Pulmonary Disease (COPD) prevalent or incident cases segmented by age, sex and subpopulations. The report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Chronic Obstructive Pulmonary Disease (COPD).

Scope of the report:

The report includes the prevalent population and how will it change over the next eight years.Prevalent or incident cases segmented by age and sex.Coverage of key Chronic Obstructive Pulmonary Disease (COPD) subpopulations and its prevalent or incident cases The key differences in epidemiology patterns across the seven market segments

Key Topics Covered:

1. Report Introduction

2. Snapshot of Total Prevalent or Incident cases by 7 MM

3. Executive Summary

4. Chronic Obstructive Pulmonary Disease (COPD) Overview

5. Etiology

6. Risk Factors Associated with Chronic Obstructive Pulmonary Disease (COPD)

7. Disease Burden & Unmet Need in the Market

8. Epidemiology and Patient Populations

9. Prevalent & Incident Cases by 7 MM-2015-2025 10. Key Takeaways

11. Appendix

For more information about this report visit https://www.researchandmarkets.com/research/4f5cgq/global_chronic?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005434/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Respiratory Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/11/2018 08:06 AM/DISC: 09/11/2018 08:06 AM

http://www.businesswire.com/news/home/20180911005434/en